Eye/Ear Drops
| S.No. | Generic Name | Composition | Ph. Ref. | Strength |
| 1 | Paradichlorobenzene, Benzocalne,Chlorbutol & Turpentine oil Ear Drops |
Composition Paradichlorobenzene Benzocaine Chlorbutol Turpentine Oil Oil Base |
I.P. I.P. B.P. |
2.P. I.P. B.P. |
| 2 | ofloxacin & Dexamethasone Sodium phosphate Eye/Ear Drops |
Composition Ofloxacin Dexamethasone Sodium phopshate Eq. to Dexamethasone Benzalkonium chloride Solu (as preservative) In a sterile aqueous buffered base |
I.P. I.P. I.P. |
0.305 w/v 0.10% w/v 0.02% v/v q.s. |
| 3 | Sulphacetamide sodium, CPM Zinc sulphate, Boric Acid & sodium chloride Eye drops |
Culphacetamide sodium, CPM Zinc sulphate, Boric Acid & sodium chloride Eye drops |
I.P. I.P. I.P. I.P. I.P. I.P. I.P. I.P. |
15% w/v 0.01% w/v 0.1% w/v 2.0% w/v 0.9% w/v 0.001% w/v 0.023% w/v 0.011% w/v q.s. |
| 4 | Phenylephrine HCI, Nephazoline HCI & Menthol Eye Drop |
Composition Phenylephrine HCI Nephazoline HCI Menthol Camphor Benzalkonium Chloride Solution (as preservative) Sterile Aqueous Buffered vehicle |
I.P. USP I.P. I.P. I.P. |
0.12% w/v 0.05% w/v 0.005% w/v 0.01 w/v 0.01% w/v q.s. |
| 5 | Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops |
Composition Potassium Iodide Calcium Chloride (Anhydrous) Sodium Chloride Phenylmercuric Nitrate (as pres.) In sterile aqueous buffer base | l.P. I.P. I.P. I.P. |
3.3 % w/v 1.0% w/v 0.83% w/v 0.001% w/v q.s. |
| 6 | Clotrinazole & Lignocaine Hydrochloride Ear Drops |
Composition Clotrimazole Lignocaine Hydrochloride In glycarine IP & Propylene Glycol Ipq |
I.P. I.P. |
1 % w/v 25 w/v q.s. |
| 7 | X ylometazoline Hydrochloride Nasal Solution IP |
Composition Xylometazoline HCI In an aqueous isotonic solution using purified water | I.P. |
0.01% w/v q.s. |
| 8 | Betamethasone Sod Phosphate, Gentamicin Eye/Ear Drop |
Each ml contains: Gentamicin Sulphate Eq. to Gentamicin Betamethasone Sodium Phosphate Benzalkonium Chloride Solution (as preservative) In sterile aqueous base |
I.P. I.P. I.P. |
0.3% w/v 0.01% w/v 0.02% w/v q.s. |
| 9 | Carboxy Methycellulose Sodium Eye Drops IP |
Composition: Carboxy Methycellulose Sodium Stablilized Oxychloro Complex (as preservative) Sterile aqueous buffered vehicle base | I.P. I.P. I.P. |
0.5% w/v 0.0075% w/v q.s. |
| 10 | Betamethasone Sod Phosphate, Ofloxacin Eye/Ear Drop |
Each ml contains: Ofloxacin Betamethasone Sodium Phosphate Benzalkonium Chloride Solution (as preservative) In sterile aqueous base |
I.P. I.P. I.P. |
0.3% w/v 0.01% w/v 0.02% v/v q.s. |
| 11 | Moxifloxacin and Dexamethasone Phosphate Eye Drops |
Each ml contains: Moxifloxacin Dexamethasone Phosphate Eq. to Dexamethasone Benzalkonium Chloride Solution In sterile aqueous buffer base | I.P. I.P. I.P. |
0.5 % 0.1% w/v 0.02% w/v q.s. |
| 12 | Betamethasone & Ciprofloxacin Eye/Ear Drops |
Each ml contains: Ciprofloxacin HCI Eq. to Ciprofloxacin Betamethasone Benzalkonium Chloride Solution (as preservative) In sterile aqueous base |
I.P. I.P. I.P. |
0.3% w/v 0.01% w/v 0.02% w/v q.s. |
| 13 | Gentamicin Sulphate Eye/Ear Drops |
Composition: Gentamicin Sulphate Eq. to Gentamicin Sodium Methyl Hydroxide Benzoate (as preservative) In sterile aqueous buffer base |
I.P. I.P. |
0.3% w/v 0.1 % w/v q.s. |
| 14 | moxifloxacin Eye Drpos IP |
composition: Moxifloxacin Hydrochloride Eq. to Moxifloxacin In sterile aqueous buffer base |
I.P. |
0.5% w/v q.s. |
| 15 | Tobramycin & Dexamethasone Sodium Phosphate Eye/Ear Drops |
Composition: Tobramycin Sulphate Eq. to Tobramycin Dexamethasone Sodium Phosphate Benzalkonium Chloride Solution (as preservative) In sterile aqueous buffer base |
I.P. I.P. I.P. |
0.3% w/v 0.5% w/v 0.025 w/v q.s. |
| 16 | Ciprofloxacin HCI Eye Drop IP | Composition Ciprofloxacin Hydrochloride Eq. to CIPROFLOXACIN Boric Acid Benzalkonium Chloride solution (as preservative) In sterile aqueous baseq |
I.P. I.P. I.P. |
0.3% w/v 0.3% w/v 0.02% w/v q.s. |
| 17 | Ciprofloxacin & Dexamethasone Eye/Ear Drops |
Composition Ciprofloxacin Hydrochloride Eq. to Ciprofloxacin Dexamethasone Benzalkonium Chloride Solution (as preservative) In sterile aqueous base |
I.P. I.P. I.P. |
0.3% w/v 0.1% w/v 0.02% w/v q.s. |
| 18 | Ciprofloxacin & HPMC Eye/Ear Drops |
Composition Ciprofloxacin Hydrochloride Eq. to Ciprofloxacin HPMC Benzalkonium Chloride Solution (as preservative) In sterile aqueous base | I.P. I.P. I.P. |
0.3% w/v 0.025% w/v 0.02% w/v q.s. |
| 19 | Gentamicin & Dexamethasone Sodium Phosphate Eye/Ear Drops |
Composition Gentamicin Sulphate Eq to Gentamicin Dexamethasone Sodium Phosphate Boric acid Benzalkonium Chloride Solution (as preservative) In sterile aqueous buffer base |
I.P. I.P. I.P. I.P. |
0.3% w/v 0.01% w/v 1.5% w/v 0.02% w/v q.s. |
| 20 | Ofloxacin Opthalmic solution IP |
Composition Ofloxacin Benzalkonium Chloride solution (as preservative) In sterile aqueous buffer base q |
I.P. I.P. |
0.3% w/v 0.02% w/v q.s. |
| 21 | Ofloxacin & Dexamethasone Sodium Phosphate Eye/Ear Drops |
Composition Ofloxacin Dexamethasone Sodium phosphate Benzalkonium chloride solution (as preservative) In sterile aqueous buffer base | I.P. I.P. I.P. |
0.35 w/v 0.015 w/v 0.02% w/v q.s. |
| 22 | Betamethasone Sodium phosphate & Chloramphenicol Eye/Ear Drop | Composition Chloramphenicol Betamethasone Sodium phopshate Benzalkonium Chloride solution (as preservative) In sterile aqueous base |
I.P. I.P. I.P. |
0.1% w/v 0.01% w/v 0.02% w/v q.s |
| 23 | Chloramphenicol, Dexamethasone Sodium Phosphate & HPMC Eye/Ear Drop |
Composition H.P.M.C Chloramphenicol Dexamethasone Sodium Phosphate Phenyl mercuric nitrtae (as preservative) In sterile aqueous buffer base |
I.P. I.P. I.P. I.P. |
0.025% w/v 0.1% w/v 0.055 w/v 0.001% w/v q.s. |
| 24 | Chloramphenicol, Dexamethasone Sodium Phosphate Eye/Ear Drop |
Composition Chloramphenicol Dexamethasone Sodium Phosphate Phenyl mercuric nitrtae (as preservative) In sterile aqueous buffer base |
I.P. I.P. I.P. |
0.5% w/v 0.05% w/v 0.001 w/v q.s. |
| 25 | Chloramphenicol Eye Drop IP |
Composition Chloramphenicol Borax Boric Acid Phenyl mercuric acetate (as preservative) In sterile aqueous base |
I.P. I.P. I.P. I.P. |
0.5% w/v 0.3% w/v 1.5% w/v 0.001 % w/v q.s. |
| 26 | Ciprofloxacin HCI Eye Drop IP |
Composition Ciprofloxacin Hydrochloride Eq. to Ciprofloxacin Benzalkonium Chloride solution (as preservative) In sterile aqueous base |
I.P. I.P. I.P. I.P. |
0.3% w/v 0.02% w/v q.s. |
| 27 | Xylometazoline HCI Nasal solution IP |
Composition Xylometazoline Hydrochloride Benzalkonium Chloride solution (as preservative) In an aqueous isotonic solution using purified water |
I.P. I.P. I.P. I.P. |
0.1% w/v 0.025 v/v q.s. |
| 28 | OOfloxacin & Dexamethasone Sodium Phosphate Eye/Ear Drops |
Composition Ofloxacin HPMC Dexamethasone sodium phopshate Benzalkonium chloride solution (as preservative) In sterile aqueous buffer base |
I.P. I.P. I.P. I.P. |
0.35 w/v 0.025% w/v 0.05% w/v 0.02% w/v q.s. |
| 29 | Moxifloxacin and Dexamethasone Sodium Phosphate Eye Drops |
Composition Moxifloxacin Hydrochloride Eq. to Moxifloxacin Dexamethasone sodium phosphate Eq. to Dexamethasone Benzalkonium Chloride solution (as preservative) In sterile aqueous buffer base |
I.P. I.P. I.P. |
0.5% w/v 0.1% w/v 0.025 v/v |
| 30 | Tobramycin sulphate and dexamethasone sodium phosphate Eye Drops | Composition Tobramycin sulphate EQ. to Tobramycin Dexamethasone sodium phosphate Benzalkonium chloride solution (as preservative) In sterile aqueous buffer base |
I.P. I.P. I.P. |
0.3% w/v 0.05% w/v 0.025 w/v |
| 31 | Neomycin,Beclomethason e,Clotrimazole and Lognocaine Ear Drops |
Composition: Neomycin Sulphate Beclomethasone Dipropionate Clotrimazole Lignocaine Hydrochloride Glycerine IP and Propylene Glycol IP Base |
I.P. I.P. I.P. |
0.5% w/v 0.025% w/v 1.0% w/v 2.0% w/v q.s. |
| 32 | Gentamicin Sulphate Eye Drop IP |
Composition: Gentamicin Sulphate Eq. to Gentamicin Sodium Methyl Hydroxyl Benzoate (as preservative) |
I.P. I.P. |
0.3% w/v 0.15 w/v |
